IMTX Immatics N.V
756
$9.82
$0.52
(5.03%)
| Watchers | 756 |
| 52-Wk Low | $7.15 |
| 52-Wk High | $13.16 |
| Market Cap | $1.01B |
| Volume | 638,639.00 |
| 52-Wk High | $13.16 |
| 52-Wk Low | $7.15 |
Maintained Buy Rating for Immatics Amid Robust Clinical Pipeline and Promising PartnershipsTipRanks Financial Blog • about 2 months ago
Immatics (IMTX Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on March 27. Analyst Graig Suvannavejh fro...
Share to Feed
This is a signal that IMTX's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Key Insights Institutions' substantial holdings in Immatics implies that they have significant influence over the...
Shares of Immatics (NASDAQ:IMTX Get Free Report) saw an uptick in trading volume on Tuesday . 566,980 shares traded hands during trading, an increase of 14% from the previous sessions...
Interim clinical data update on ACTengine IMA203 GEN1 (PRAME) in melanoma at RP2D in November 2023: 50% confirmed objective response rate with median duration of response not reached at median...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This is a Bearish indicator signaling IMTX's price could decline from here. Traders may explore shorting the stock or put options...
Quantum Genomics Soci t Anonyme (OTCMKTS:QNNTF Get Free Report) and Immatics (NASDAQ:IMTX Get Free Report) are both small-cap medical companies, but which is the superior investment...